Who has invested in BridgeBio Pharma?

Sixth Street, HealthCare Royalty are named among the investors backing BridgeBio Pharma.

BridgeBio Pharma Funding: $1B Raised, Growth (2026)

BridgeBio Pharma funding overview

BridgeBio Pharma is based in Palo Alto. BridgeBio Pharma has raised $1B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is a Growth announced in July 2026. The round record for BridgeBio Pharma runs through 2026; nothing later has been disclosed. Investors on record include Sixth Street, HealthCare Royalty. 2 distinct backers are named across the disclosed rounds.

BridgeBio Pharma at a glance

Total raised: $1B
Latest round: Growth
Latest round date: July 2026
Headquarters: Palo Alto
Notable investors: Sixth Street, HealthCare Royalty

Frequently asked about BridgeBio Pharma funding

How much has BridgeBio Pharma raised?: BridgeBio Pharma has raised $1B in total disclosed funding across the rounds on record.
Who has invested in BridgeBio Pharma?: Sixth Street, HealthCare Royalty are named among the investors backing BridgeBio Pharma.
What was the latest BridgeBio Pharma funding round?: The most recent disclosed round is a Growth, announced in July 2026.
Where is BridgeBio Pharma based?: BridgeBio Pharma is based in Palo Alto.
When did BridgeBio Pharma last raise?: The last disclosed BridgeBio Pharma round closed in July 2026 at Growth.

Totals shown for BridgeBio Pharma aggregate every disclosed round on file. To see how that compares, browse the companies in Palo Alto and the investors behind them below.

BridgeBio Pharma Funding: $1B Raised, Growth (2026)

BridgeBio Pharma funding overview

BridgeBio Pharma at a glance

Frequently asked about BridgeBio Pharma funding

Companies related to BridgeBio Pharma (33)

Browse related funding lists (6)